Loading clinical trials...
Loading clinical trials...
The Accuracy of Digital Assessment of Performance Trial (ADAPT): Walk Test Study
The aim of this study is to investigate whether a smartwatch can measure the physical capacity of patients with Parkinson's Disease and COPD in the physiotherapy practice and at home.
Physical capacity and physical activity are important factors for healthy aging and are found to be predictors of disability, morbidity and mortality in healthy older adults and in people with chronic diseases like Parkinson's Disease and COPD. Physical capacity and activity have mainly been assessed in in-clinic settings using standardized tests and subjective questionnaires. Relying only on in-clinic tests is suboptimal because the tests give limited information on how a patient functions in daily life and cannot capture fluctuations and subtle decrements in disease symptoms. With the rise of innovative technology like wearable sensors, both aspects have become measurable in the patients daily life. Here, the investigators will study a wrist worn device (The Verily Study Watch) that has the ability to measure physical activity and physical capacity passively and remotely. The primary focus is on its opportunity to measure physical capacity using the 6MWT, referred to as the virtual 6MWT. The watch tags the start and end of the 6 minutes when performing this test. Also, participants can perform the test independently at home. The Study Watch has the options for remote testing of the Timed Up and Go test (TUG) as well. The aim of this study is to investigate whether the virtual 6MWT validly predicts 6MWT outcomes as measured during a supervised, in-clinic test. A valid virtual 6MWT will be extremely valuable for assessing physical capacity in the home situation longitudinally. This will contribute to a more effective and personalized treatment for people with chronic diseases. The study has a duration of 15 weeks, with 4 in-clinic visits at the physiotherapy practice every five weeks. During those visits, several physical capacity tests will be performed alongside tests and questionnaires related to demographics and disease status. Participants will perform the 6MWT and TUG at home on a weekly basis on a pre-set day and time using the Verily Study Watch. Between week 5 and 15 of the study, participants will follow a standardized aerobic exercise training program according to the most recent regulations.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Paca
Aalsmeer, Netherlands
Gezondheidscentrum Marne
Amstelveen, Netherlands
Fysiotherapie Heusdenhout
Breda, Netherlands
Praktijk Graaf Hendrik III Laan
Breda, Netherlands
RevaQ
Breda, Netherlands
Lijf & leven, fit en fysiotherapie
Ede, Netherlands
Fysiotherapie De Hertog
Franeker, Netherlands
Zorggroep Ter Weel
Goes, Netherlands
Fysio Heerde
Heerde, Netherlands
Tigra
Heerenveen, Netherlands
Start Date
December 23, 2021
Primary Completion Date
November 30, 2023
Completion Date
November 30, 2023
Last Updated
March 12, 2025
154
ACTUAL participants
Aerobic exercise training
BEHAVIORAL
Lead Sponsor
Radboud University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06692920